Kothari Fermentation & Biochem FY26 Results: Net loss widens to ₹298.93 lakh
- Net loss widened to ₹298.93 lakh in FY26 from a profit of ₹80.99 lakh in FY25
- Revenue declined 1.84% to ₹11,213.19 lakh despite a 5.38% rise in production volumes
- Operating profit margin contracted to 0.21% from 4.77% due to higher input costs
- 36th AGM scheduled for September 30, 2026, to approve director remuneration revisions
- No dividend recommended for the financial year ended March 31, 2026

*this image is generated using AI for illustrative purposes only.
Kothari Fermentation & Biochem reported a net loss of ₹298.93 lakh for the financial year ended March 31, 2026, a reversal from the net profit of ₹80.99 lakh recorded in FY25. The company’s revenue declined by 1.84% to ₹11,213.19 lakh, driven by higher raw material costs and competitive pricing pressures. Production volumes rose 5.38% to 16,102 MT, yet capacity utilization stood at 76.68% against an operative capacity of 21,000 MT per annum.
The board has scheduled the 36th Annual General Meeting (AGM) for Wednesday, September 30, 2026, at 11:30 am. The meeting will be conducted via video conferencing or other audio-visual means. Key agenda items include the re-appointment of Chairman and Managing Director Pramod Kumar Kothari and special resolutions to revise the remuneration of both Mr. Kothari and Whole-Time Director Mrs. Kavita Devi Kothari.
Financial Performance
The company’s operating profit margin contracted sharply to 0.21% from 4.77% in the previous year. Profit before tax swung to a loss of ₹346.23 lakh from a profit of ₹193.86 lakh. Finance costs increased marginally to ₹369.93 lakh, while depreciation expenses rose to ₹700.24 lakh. The current ratio improved to 1.91 from 1.08, primarily due to a reduction in current liabilities during the year.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | ₹11,213.19 lakh | ₹11,423.10 lakh | -1.84% |
| PBT | (₹346.23) lakh | ₹193.86 lakh | Turn to loss |
| Net Profit/Loss | (₹298.93) lakh | ₹80.99 lakh | Turn to loss |
| Production (MT) | 16,102 | 15,280 | +5.38% |
What the Numbers Show
Despite a 5.38% increase in production volume, revenue declined, indicating a compression in average selling prices or a shift toward lower-margin product variants. The operating profit before interest and tax (PBDIT) fell significantly to ₹723.94 lakh from ₹1,196.51 lakh, highlighting that volume growth was insufficient to offset rising input costs and lower operating profitability. Additionally, foreign exchange earnings dropped to nil from ₹180.50 lakh in FY25, suggesting a potential contraction in export activities or a strategic pivot toward domestic markets.
Corporate Governance and Remuneration
The AGM will seek approval for revised remuneration packages for key promoters effective from April 1, 2026, to March 31, 2028. Mr. Pramod Kumar Kothari’s proposed monthly salary is ₹6,00,000, while Mrs. Kavita Devi Kothari’s is set at ₹5,75,000. Both resolutions include provisions for minimum remuneration payable even in the event of no profits or inadequate profits.
Dr. Rajiv Agarwal resigned as an Independent Director on August 13, 2025, due to professional commitments. Mr. Varun Kumar was appointed as an Additional Director and subsequently as an Independent Director with member approval on September 30, 2025. The company did not recommend any dividend for FY26.
Historical Stock Returns for Kothari Fermentation & Biochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.43% | -0.73% | -6.67% | +7.52% | -13.60% | 0.0% |
How does the proposed revision of promoter remuneration, including minimum guarantees during loss-making periods, impact shareholder value and corporate governance perceptions?
What specific strategic initiatives is the company planning to address the sharp contraction in operating margins and the complete loss of foreign exchange earnings?
Will the company pursue capacity expansion or operational efficiency measures to improve the 76.68% utilization rate and offset rising raw material costs?


































